• Corpus ID: 16160859

Omega-3 DHA and EPA for cognition, behavior, and mood: clinical findings and structural-functional synergies with cell membrane phospholipids.

  title={Omega-3 DHA and EPA for cognition, behavior, and mood: clinical findings and structural-functional synergies with cell membrane phospholipids.},
  author={Parris M. Kidd},
  journal={Alternative medicine review : a journal of clinical therapeutic},
  volume={12 3},
  • P. Kidd
  • Published 1 September 2007
  • Psychology
  • Alternative medicine review : a journal of clinical therapeutic
The omega-3 fatty acids docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) are orthomolecular, conditionally essential nutrients that enhance quality of life and lower the risk of premature death. They function exclusively via cell membranes, in which they are anchored by phospholipid molecules. DHA is proven essential to pre- and postnatal brain development, whereas EPA seems more influential on behavior and mood. Both DHA and EPA generate neuroprotective metabolites. In double-blind… 

Figures from this paper

The effects of Omega-3 polyunsaturated fatty acid supplementation on neurocognitive functioning in healthy young adults
The principle of neural efficiency as established by Richard Haier (“smart brains work less hard”) was extended to apply to the neurocognitive effects of omega-3 supplementation and improved mental processing speed and reduced nonlinear components of the Visual Evoked Potentials (VEPs) for high contrast stimulation.
The Importance of Marine Omega-3s for Brain Development and the Prevention and Treatment of Behavior, Mood, and Other Brain Disorders
Evidence indicates that a low intake of marine omega-3s increases the risk for numerous mental health issues, including Attention Deficit Hyperactivity Disorder (ADHD), autism, bipolar disorder, depression and suicidal ideation.
Omega 3 Fatty Acids: Novel Neurotherapeutic Targets for Cognitive Dysfunction in Mood Disorders and Schizophrenia?
Current data predominantly from mechanistic models and animal studies suggest that adjunctive omega-3 fatty acid supplementation could lead to improved cognitive functioning in SZ and affective disorders, however, besides its translational promise, evidence for clinical benefits in humans has been mixed.
The role of omega-3 for improvement of mood, behavior and communication skills in children
Adequate dietary availability of DHA and EPA is fundamental to brain function, as well as during the brain growth spurts that characterize pre-natal and post natal development.
Omega-3 Fatty Acids and Depression: Scientific Evidence and Biological Mechanisms
Tertiary prevention with omega-3 PUFA supplement in depressed patients has reached greater effectiveness during the last recent years, although definitive statements on their use in depression therapy cannot be yet freely asserted.
Effects of Omega 3 Fatty Acids on Main Dimensions of Psychopathology
The present systematic review is aimed to examine the available data on the efficacy of omega-3 fatty acids on domains of psychotic symptoms, affective symptoms, impulsivity, and aggressiveness, and harmful behaviors, and suicide risk.
Impact of fatty acids on brain circulation, structure and function.
  • R. HaastA. Kiliaan
  • Biology, Medicine
    Prostaglandins, leukotrienes, and essential fatty acids
  • 2015
Effects of omega-3 fatty acid supplementation on neurocognitive functioning and mood in deployed U.S. soldiers: a pilot study.
Although the results revealed that omega-3 FAs significantly increased the HS-Omega-3 Index (p = 0.001), there were no significant effects on indices psychological health and neurocognitive functioning by treatment group.


Omega-3 fatty acids in ADHD and related neurodevelopmental disorders
  • A. Richardson
  • Psychology, Medicine
    International review of psychiatry
  • 2006
Omega-3 is not supported by current evidence as a primary treatment for ADHD or related conditions, but given their relative safety and general health benefits, omega-3 fatty acids offer a promising complementary approach to standard treatments.
Dietary omega-3 fatty acids normalize BDNF levels, reduce oxidative damage, and counteract learning disability after traumatic brain injury in rats.
The results imply that omega-3 enriched dietary supplements can provide protection against reduced plasticity and impaired learning ability after traumatic brain injury.
A placebo-controlled trial of omega-3 fatty acid (ethyl eicosapentaenoic acid) supplementation for residual symptoms and cognitive impairment in schizophrenia.
For schizophrenia patients treated with 3 g/day of ethyl EPA, improvement in residual symptoms and cognitive impairment was no greater than for schizophrenia patients treating with placebo.
Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial.
Administration of omega-3 fatty acid in patients with mild to moderate AD did not delay the rate of cognitive decline according to the MMSE or the cognitive portion of the Alzheimer Disease Assessment Scale, and positive effects were observed in a small group of patients with very mild AD.
EFA supplementation in children with inattention, hyperactivity, and other disruptive behaviors
The results of this pilot study suggest the need for further research with both n−3 FA and vitamin E in children with behavioral disorders.
Omega-3 fatty acids in bipolar disorder: clinical and research considerations.
The major psychoses and neuroses as omega-3 essential fatty acid deficiency syndrome: substrate pellagra.
This preliminary study finds that the existence of therapeutically cross-reacting homologous catalyst and substrate deficiency forms of pellagra are postulated, the first contributing to the B vitamin deficiency epidemics of 50-100 years ago, the second to the more recent endemic "Diseases of Western Civilization" which express in certain genetic subgroups as the major mental illnesses of today.